Thursday, October 2, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Anticipating CryoPorts Earnings Report Analysis and Expectations

Elaine Mendonca by Elaine Mendonca
March 11, 2024
in Breaking News
0
Logistics Stock Market Today (2)
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Earnings Preview for CryoPort (NASDAQ: CYRX)

CryoPort is set to unveil its quarterly earnings report on March 12, 2024. Analysts are predicting an earnings per share (EPS) of $-0.29 for the company. Investors are eagerly awaiting the results to see if CryoPort can exceed expectations and offer positive guidance for future growth, which could have a significant impact on stock prices.

Performance Overview:
In the previous quarter, CryoPort missed EPS estimates by $0.00, but the share price still saw a 10.03% increase the next day. Here’s a snapshot of CryoPort’s recent performance:
– Q3 2023: EPS Estimate: -0.31, EPS Actual: -0.31, Price Change %: 10.0%
– Q2 2023: EPS Estimate: -0.24, EPS Actual: -0.42, Price Change %: -2.0%
– Q1 2023: EPS Estimate: -0.19, EPS Actual: -0.16, Price Change %: 14.00%
– Q4 2022: EPS Estimate: -0.19, EPS Actual: -0.24, Price Change %: 9.0%

Stock Performance:
As of March 8, CryoPort’s shares were trading at $16.85, reflecting a negative return of 21.85% over the past year. Long-term investors may be feeling bearish leading up to the earnings announcement.

Investors seeking more in-depth information on CryoPort’s earnings track record and stock performance can explore various platforms like Nasdaq, TipRanks, MarketBeat, and Seeking Alpha.

Cryoport, Inc. (CYRX) Sees Slight Decrease in Stock Price on March 11, 2024: What Investors Need to Know

On March 11, 2024, Cryoport, Inc. (CYRX) saw a slight decrease in its stock price, with shares dropping by $0.12 or 0.68% since the previous market close. The stock opened at $16.65, which was $0.20 lower than its previous close.

Despite the drop in price on this particular day, CYRX is still trading in the middle of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been relatively stable over the long term, with its current price reflecting a moderate level of volatility.

Investors may be keeping an eye on CYRX to see if the slight decrease in price on March 11 is a temporary dip or the start of a larger trend. It’s important to note that stock prices can fluctuate for a variety of reasons, including market conditions, company performance, and external factors.

Cryoport Inc. (CYRX) Reports Mixed Financial Results for 2023, Shows Signs of Improvement

On March 11, 2024, Cryoport Inc. (CYRX) saw a mixed performance in its stock as the company reported its financial results for the past year and the third quarter. Cryoport’s total revenue for the past year was $237.28 million, with a quarterly revenue of $56.16 million. The total revenue increased by 6.59% since the previous year but remained flat compared to the previous quarter. Cryoport reported a net loss of $37.33 million for the past year and a net loss of $13.27 million for the third quarter. Despite the losses, Cryoport’s net income increased by 86.45% since the previous year and by 27.71% since the previous quarter. Earnings per share (EPS) for Cryoport were reported at -$0.93 for the past year and -$0.31 for the third quarter. The EPS increased by 85.02% since the previous year and by 25.29% since the previous quarter. Overall, Cryoport’s financial performance showed signs of improvement, with increases in net income and EPS compared to the previous year and quarter. Investors will likely be monitoring Cryoport’s future financial results to see if the company can continue its upward trajectory and turn its losses into profits.

Tags: CYRX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Pickleball sports

Anticipated Earnings Report for Manchester United Analyzing Past Performance and Future Expectations

Finance analyst

Analyst Reiterates Market Perform Rating on Enhabit with Revised Price Target

Airbnb Implements Worldwide Ban on Indoor Security Cameras

Recommended

Iridex Corporation Acquires European Patent for Groundbreaking MicroPulse Technology in Ophthalmology and Retinal Diseases

2 years ago
Tenet Healthcare Stock

Tenet Healthcare’s Rally Faces Regulatory Headwinds

2 weeks ago
Eli Lilly Stock

Eli Lilly Shares Plunge: Market Overreaction or Justified Selloff?

1 month ago

Decrease in Short Interest Indicates Bullish Sentiment Towards RPM International Inc

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray TSLA Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Toughbuilt Industries Shares Plummet in Catastrophic Market Collapse

Biogen’s Global Expansion and Promising Data Fuel Alzheimer’s Treatment Optimism

Is Axsome Therapeutics Positioned to Lead the Neuroscience Revolution?

UnitedHealth’s Strategic Pivot Faces Critical Test Amid Industry Pressures

Noble Corporation Completes Acquisition of Diamond Offshore Drilling

Media Giant Warner Bros. Discovery Faces Potential Acquisition Battle

Trending

aTyr Pharma Stock
Analysis

Clinical Trial Failure Sends aTyr Pharma Shares into Freefall

by Dieter Jaworski
October 2, 2025
0

aTyr Pharma's stock continues its downward spiral as disappointing clinical trial results trigger a massive selloff. The...

Workday Stock

Workday’s Strategic AI Acquisition Sparks Investor Optimism

October 2, 2025
Autodesk Stock

Autodesk Stock Positioned for AI-Driven Growth

October 2, 2025
Toughbuilt Industries Stock

Toughbuilt Industries Shares Plummet in Catastrophic Market Collapse

October 2, 2025
Biogen Stock

Biogen’s Global Expansion and Promising Data Fuel Alzheimer’s Treatment Optimism

October 2, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Clinical Trial Failure Sends aTyr Pharma Shares into Freefall
  • Workday’s Strategic AI Acquisition Sparks Investor Optimism
  • Autodesk Stock Positioned for AI-Driven Growth

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com